Skip to main content
. 2020 Apr 9;23(7):426–433. doi: 10.1093/ijnp/pyaa027

Table 3.

Shift of Treatment Frequency of Esketamine Nasal Spray from Week 4 to Week 8, Week 24, and Week 44 of the Optimization/Maintenance Phase

Regimen at week 4
Every other week Weekly Total
Regimen at week 8
 Every other week, 189 (35.9%) 78 (14.8%) 267 (50.8%)
 Weekly, and 61 (11.6%) 198 (37.6%) 259 (49.2%)
 Total 250 (47.5%) 276 (52.5%) 526 (100.0%)
Regimen at week 24
 Every other week, 138 (39.4%) 65 (18.6%) 203 (58.0%)
 Weekly, and 41 (11.7%) 106 (30.3%) 147 (42.0%)
 Total 179 (51.1%) 171 (48.9%) 350 (100.0%)
Regimen at week 44
 Every other week, 71 (41.3%) 39 (22.7%) 110 (64.0%)
 Weekly, and 17 (9.9%) 45 (26.2%) 62 (36.0%)
 Total 88 (51.2%) 84 (48.8%) 172 (100.0%)

Note: Data presented as the number and percentage of patients within each week.